Functional compensation of the low platelet count by increased individual platelet size in a patient with May-Hegglin anomaly presenting with acute myocardial infarction.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  International Journal of Cardiology

• Publication date

  1998-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0167-5273(98)00043-6PMID 9688436
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions.

  1998cited by this paper
• Von Willebrand Factor‐Dependent Shear‐Induced Platelet Aggregation: Basic Mechanisms and Clinical Implications

  1997cited by this paper
• Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor.

  1996cited by this paper
• Characterization of the Unique Mechanism Mediating the Shear-dependent Binding of Soluble von Willebrand Factor to Platelets (*)

  1995cited by this paper
• The pathogenesis of coronary artery disease and the acute coronary syndromes (2).

  1992cited by this paper
• Epinephrine Augments von Willebrand Factor‐Dependent Shear‐Induced Platelet Aggregation

  1992cited by this paper
• The pathogenesis of coronary artery disease and the acute coronary syndromes (1).

  1992cited by this paper
• The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress.

  1991cited by this paper
• Coronary thrombosis in a patient with May-Hegglin anomaly.

  1991cited by this paper
• Textbook of Hematology

  1988cited by this paper
• Blood : textbook of hematology

  1987cited by this paper
• Increased surface expression of the membrane glycoprotein IIb/IIIa complex induced by platelet activation. Relationship to the binding of fibrinogen and platelet aggregation.

  1987cited by this paper
• The von Willebrand factor-binding domain of platelet membrane glycoprotein Ib. Characterization by monoclonal antibodies and partial amino acid sequence analysis of proteolytic fragments.

  1986cited by this paper
• Evidence for Glycoprotein Abnormality in Platelets from Patients with May-Hegglin Anomaly

  1985cited by this paper
• Arteriosclerosis in Normal and von Willebrand Pigs: Long‐Term Prospective Study and Aortic Transplantation Study

  1982cited by this paper
• Platelet membrane studies in the May-Hegglin anomaly.

  1981cited by this paper
• Platelet function, ultrastructure, and survival in the May-Hegglin anomaly.

  1980cited by this paper
• Inhibition of Injury Induced Thromboatherosclerotic Lesions by Anti-Platelet Serum in Rabbits

  1976cited by this paper
• Conjugation of fluorescein isothiocyanate to antibodies. I. Experiments on the conditions of conjugation.

  1970cited by this paper

• Effects of caplacizumab, a specific inhibitor of the A1 domain of von Willebrand factor binding with platelet membrane glycoprotein (GP) Ibα, on the length of platelet pseudopods supporting platelet adhesions on immobilized von Willebrand factor under blood flow condition

  2022cites this paper
• Why thromboembolism occurs in some patients with thrombocytopenia and treatment strategies.

  2020cites this paper
• What is the meaning of P2Y12 reaction units in patients with essential thrombocythemia?

  2015cites this paper
• Myocardial Infarctions and Other Acute Coronary Syndromes in Rare Congenital Bleeding Disorders

  2015cites this paper
• Editorial Comment for the "Risk of Thrombocytopenia with Glycoprotein IIb/IIIa Inhibitors across Drugs and Patient Populations: a Meta-Analysis of 29 Large Placebo-Controlled Randomized Trials". Thrombocytopenia as an important complication with the use of antithrombotic agents.

  2015cites this paper
• Thrombin generation in two families with MYH9-related platelet disorder

  2014cites this paper
• Etude des mécanismes de formation des plaquettes sanguines : rôle de l'environnement médullaire

  2014cites this paper
• fluid shear stress Platelet-VWF complexes are preferred substrates of ADAMTS13 under

  2013cites this paper
• shear stress Platelet-VWF complexes are preferred substrates of ADAMTS13 under fluid

  2013cites this paper
• Occurrence of thrombosis in congenital thrombocytopenic disorders: a critical annotation of the literature

  2013cites this paper
• Romiplostim administration shows reduced megakaryocyte response-capacity and increased myelofibrosis in a mouse model of MYH9-RD.

  2012cites this paper
• Recent advances in the understanding and management of MYH9‐related inherited thrombocytopenias

  2011cites this paper
• Thrombotic events in MYH9 gene-related autosomal macrothrombocytopenias (old May-Hegglin, Sebastian, Fechtner and Epstein syndromes).

  2011cites this paper
• Thrombotic events in MYH9 gene-related autosomal macrothrombocytopenias (old May–Hegglin, Sebastian, Fechtner and Epstein syndromes)

  2011cites this paper
• Intriguing outcome of JAK2V617F mutation seen in a patient with MYH9-related hereditary macrothrombocytopenia

  2010cites this paper
• Platelet-VWF complexes are preferred substrates of ADAMTS13 under fluid shear stress.

  2008cites this paper
• Cerebral infarction in a patient with macrothrombocytopenia with leukocyte inclusions (MTCP, May-Hegglin anomaly/Sebastian syndrome).

  2008cites this paper
• fluid shear stress Platelet-VWF complexes are preferred substrates of ADAMTS 13 under

  2007cites this paper
• May–Hegglin anomaly: the role of aspirin in the treatment of this rare platelet disorder in pregnancy

  2002cites this paper
• Biochemical hematology of platelets and leukocytes.

  2001cites this paper
• Inherited giant platelet disorders. Classification and literature review.

  2000cites this paper